Phage Therapy Breakthrough

A groundbreaking case showcases the successful use of genetically engineered phages to treat a bacterial infection in a human for the first time. After undergoing intravenous phage therapy, an 18-year-old made a remarkable recovery, raising hopes for future treatments of serious infections like tuberculosis. This innovative approach not only demonstrates the potential of phage therapy but also challenges conventional views on genetic modification.